Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Disease area: Airway diseases

Abstract

Chronic non-communicable diseases(CNCDs) aresome of the most widespread diseases and a leading cause of death around the world. Application of telemedicine technologies for remote CNCD monitoring is currently a promising global solution to the problem of CNCDs, since it is aimed at eliminating the main causes of treatment failures and (or) loss of control of a disease, such as inadequate therapy, rare pulmonary function assessment and low patient compliance. In order to implement this solution on a large scale,it is necessary to evaluate its cost-effectiveness (EC).The objective of the study was to analyze the CEof the doctor-patient remote monitoring system (MS)of CNCDs.The effectiveness of a web-based disease monitoring technology was evaluated by the frequency of hospitalizations of patients with bronchial asthma (BA). This solution ensures long-term control of the disease through regular monitoring of the disease dynamics by a patient and a doctor. A medical facility serving 20 000 population was the object of the study.Given the average prevalence of asthma in the population, the average compliance rate among BA patients according to pharmacoeconomic studies and the cost of a hospitalization case in mandatory health insurance system, the direct costs of the medical facility associated with hospitalization of BA patients will amount to 3.6 mn. roubles a year. Thus, implementation of the remote MS of CNCDs will save the medical institution around 1.5 mn. roubles annually.Therefore, implementation of the doctor-patient remote MS of CNCDs demonstrates significant CE through the example of a typical medical facility.


Rating:

Share or cite this content

Citations should be made in the following way:
Evgeny Kulikov (Tomsk, Russian Federation), Evgeny Kulikov, Olga Kobaykova, Ivan Deev, Vadim Boykov, Alexndra Golubeva. Assessing the cost-effectivenessof the doctor-patient remotemonitoring system of chronic non-communicable diseases. Eur Respir J 2016; 48: Suppl. 60, 1031

Member's Comments

No comment yet.

Related content which might interest you: The multicomponent nature of difficult asthma Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Childhood obesity in relation to poor asthma control and exacerbations Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Psychophysiology of depression in bronchial asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 What is important to people with asthma: Maximising research impact? Source: International Congress 2015 – Any news from the asthma field? Year: 2015 Risk factors of fixed airway obstruction in elderly patients with asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Priorities for asthma R&D in Europe: A systematic approach Source: International Congress 2016 – Asthma points to ponder Year: 2016 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 The impact of a specialist multi-disciplinary approach on burden of frequent asthma admissions Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 The real world burden of illness in uncontrolled asthma with elevated eosinophils Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD) Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Poor adherence to ICS treatment in patients with chronic respiratory diseases Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Developing integrated mental health and asthma treatment protocol using quality improvement methods Source: International Congress 2016 – Asthma points to ponder Year: 2016 Factors associated with irreversible airway obstruction in patients with asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Does small-airways dysfunction predispose to greater perceived respiratory symptoms during bronchoconstriction in asthma? Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014